Trial intelligence / Profile preview

Rose oil versus omeprazole for gastro-esophageal reflux disease

IRCT2014101119489N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of rose oil and omeprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Tehran University of Medical Sciences. Started Dec 2015; status: completed.

02

Drugs

rose oilomeprazole
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on IRCT2014101119489N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014101119489N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call